Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Accounts Payables (2020 - 2025)

Bio Essence has reported Accounts Payables over the past 6 years, most recently at $35854.0 for Q4 2025.

  • For Q4 2025, Accounts Payables rose 102.13% year-over-year to $35854.0; the TTM value through Dec 2025 reached $35854.0, up 102.13%, while the annual FY2025 figure was $35854.0, 102.13% up from the prior year.
  • Accounts Payables for Q4 2025 was $35854.0 at Bio Essence, up from $5725.0 in the prior quarter.
  • Over five years, Accounts Payables peaked at $466001.0 in Q1 2021 and troughed at $5725.0 in Q3 2025.
  • A 5-year average of $108500.3 and a median of $50300.5 in 2022 define the central range for Accounts Payables.
  • Biggest five-year swings in Accounts Payables: surged 126875.75% in 2021 and later plummeted 96.81% in 2025.
  • Year by year, Accounts Payables stood at $77109.0 in 2021, then tumbled by 70.13% to $23029.0 in 2022, then crashed by 45.92% to $12453.0 in 2023, then skyrocketed by 42.44% to $17738.0 in 2024, then surged by 102.13% to $35854.0 in 2025.
  • Business Quant data shows Accounts Payables for BIOE at $35854.0 in Q4 2025, $5725.0 in Q3 2025, and $10692.0 in Q2 2025.